{"id":"W2596883961","doi":"10.1200/jco.2016.70.7257","title":"Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline","year":2017,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":223,"is_retracted":false,"has_abstract":true,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Medicine; Denosumab; Zoledronic acid; Breast cancer; Guideline; Internal medicine; Oncology; Adjuvant; Adjuvant therapy; Cancer; Clinical trial; Osteonecrosis of the jaw; Bisphosphonate; Osteoporosis; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008459711,0.001067019,0.0023868,0.00382484,0.001543281,0.001697673,0.004845056,0.004713009,0.004842127],"category_scores_gemma":[0.02004554,0.0007539,0.003507066,0.004746565,0.001070662,0.001440346,0.001788183,0.004791509,0.002733429],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01160539,"about_ca_system_score_gemma":0.03831774,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.192667,"about_ca_topic_score_gemma":0.2921468,"domain_scores_codex":[0.9909474,0.002155191,0.002749689,0.0004222495,0.00321521,0.0005100728],"domain_scores_gemma":[0.9715042,0.003578551,0.00468606,0.0004375612,0.0179217,0.00187186],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001289387,0.0001682203,0.003365885,0.01390647,0.0003512045,0.0002423872,0.0002715112,0.0009325317,0.0006103739,0.002309307,0.7730039,0.2047094],"study_design_scores_gemma":[0.0008001649,0.0001647053,0.0171136,0.05938563,0.001099241,0.0005939832,0.0002999517,0.001298276,0.0004062626,0.004181589,0.9145308,0.0001258018],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"review","genre_scores_codex":[0.00635797,0.3927532,0.01824398,0.4076295,0.0127851,0.01470777,0.02549898,0.001107732,0.1209159],"genre_scores_gemma":[0.05226453,0.5187683,0.1646989,0.1578178,0.00604769,0.01712089,0.04414229,0.0003809218,0.03875872],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.192667,"threshold_uncertainty_score":0.3830911,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.5669481703085816,"score_gpt":0.6544656793088844,"score_spread":0.08751750900030286,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}